Sunesis Pharmaceuticals, Inc. Gains 24.3%
Wed, Mar 03, 2021 at 05:30 PM
Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ) rocketted at $5.32, a gain of 24.3%. The stock got featured on our News Catalysts scanner on Wed 24 Feb 21 at 04:49 PM in the 'MERGER' category. From Tue 16 Feb 21, the stock recorded 30.00% Up Days and 72.73% Green Days
The stock spiked on Wed 24 Feb 21 at $7.09 with a volume of 70M+.
About Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ)
Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
Top 10 Gainers:
- Cohen & Company Inc. (COHN:NYSEMKT), 133.62%
- VectoIQ Acquisition Corp. (VTIQ:NASDAQ), 100%
- Veritiv Corporation (VRTV:NYSE), 40.99%
- 1895 Bancorp of Wisconsin, Inc. (BCOW:NASDAQ), 37.44%
- Ovid Therapeutics Inc. (OVID:NASDAQ), 36.49%
- Super League Gaming, Inc. (SLGG:NASDAQ), 29.93%
- YGMZ (YGMZ:NASDAQ), 25.18%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%
- The Michaels Companies, Inc. (MIK:NASDAQ), 22.2%
- Nam Tai Property Inc. (NTP:NYSE), 21.44%